Market Closed -
Hong Kong S.E.
01:38:24 08/07/2024 pm IST
|
5-day change
|
1st Jan Change
|
0.88
HKD
|
+1.15%
|
|
+3.53%
|
-4.35%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
604.6
|
575.8
|
476
|
456.8
|
425.7
|
411.2
|
Enterprise Value (EV)
1 |
684.7
|
670.8
|
704.6
|
790.7
|
1,010
|
1,092
|
P/E ratio
|
25.9
x
|
24.2
x
|
11.7
x
|
12.9
x
|
19.1
x
|
9.44
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.49
x
|
1.4
x
|
0.84
x
|
0.96
x
|
0.8
x
|
0.58
x
|
EV / Revenue
|
1.69
x
|
1.63
x
|
1.24
x
|
1.66
x
|
1.89
x
|
1.55
x
|
EV / EBITDA
|
15.1
x
|
11.9
x
|
7.04
x
|
14.9
x
|
34.4
x
|
15
x
|
EV / FCF
|
-73.5
x
|
10.8
x
|
-22.7
x
|
-5.43
x
|
-4.85
x
|
-14.2
x
|
FCF Yield
|
-1.36%
|
9.27%
|
-4.4%
|
-18.4%
|
-20.6%
|
-7.03%
|
Price to Book
|
1.56
x
|
1.76
x
|
1.5
x
|
1.21
x
|
1.14
x
|
1.01
x
|
Nbr of stocks (in thousands)
|
4,91,800
|
4,91,800
|
4,91,800
|
4,91,800
|
4,91,800
|
4,91,800
|
Reference price
2 |
1.229
|
1.171
|
0.9679
|
0.9289
|
0.8655
|
0.8362
|
Announcement Date
|
25/04/19
|
14/05/20
|
23/04/21
|
28/04/22
|
27/04/23
|
19/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
405
|
412.6
|
566.3
|
476.4
|
534.7
|
705.8
|
EBITDA
1 |
45.47
|
56.23
|
100
|
53.2
|
29.39
|
73
|
EBIT
1 |
35.54
|
46.73
|
90.7
|
41.95
|
18.49
|
61.68
|
Operating Margin
|
8.78%
|
11.33%
|
16.02%
|
8.81%
|
3.46%
|
8.74%
|
Earnings before Tax (EBT)
1 |
28.68
|
31.33
|
53.11
|
40.05
|
24.74
|
48.5
|
Net income
1 |
23.24
|
23.75
|
40.52
|
35.5
|
22.32
|
43.58
|
Net margin
|
5.74%
|
5.76%
|
7.15%
|
7.45%
|
4.17%
|
6.17%
|
EPS
2 |
0.0475
|
0.0483
|
0.0824
|
0.0722
|
0.0454
|
0.0886
|
Free Cash Flow
1 |
-9.315
|
62.16
|
-31
|
-145.7
|
-208.2
|
-76.79
|
FCF margin
|
-2.3%
|
15.07%
|
-5.47%
|
-30.57%
|
-38.94%
|
-10.88%
|
FCF Conversion (EBITDA)
|
-
|
110.54%
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
261.72%
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
25/04/19
|
14/05/20
|
23/04/21
|
28/04/22
|
27/04/23
|
19/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
80.1
|
95.1
|
229
|
334
|
585
|
680
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.763
x
|
1.691
x
|
2.285
x
|
6.276
x
|
19.9
x
|
9.321
x
|
Free Cash Flow
1 |
-9.31
|
62.2
|
-31
|
-146
|
-208
|
-76.8
|
ROE (net income / shareholders' equity)
|
6.24%
|
6.64%
|
12.4%
|
9.97%
|
5.85%
|
11.1%
|
ROA (Net income/ Total Assets)
|
3.09%
|
3.79%
|
7.06%
|
2.92%
|
1.11%
|
3.04%
|
Assets
1 |
751.6
|
627.2
|
573.9
|
1,214
|
2,012
|
1,435
|
Book Value Per Share
2 |
0.7900
|
0.6700
|
0.6500
|
0.7700
|
0.7600
|
0.8300
|
Cash Flow per Share
2 |
0.1400
|
0.1000
|
0.1100
|
0.0500
|
0.1000
|
0.0600
|
Capex
1 |
14.6
|
2.04
|
96.7
|
131
|
162
|
109
|
Capex / Sales
|
3.6%
|
0.49%
|
17.07%
|
27.48%
|
30.26%
|
15.47%
|
Announcement Date
|
25/04/19
|
14/05/20
|
23/04/21
|
28/04/22
|
27/04/23
|
19/04/24
|
|
1st Jan change
|
Capi.
|
---|
| -4.35% | 5.48Cr | | +20.09% | 6.8TCr | | -5.55% | 4.63TCr | | +23.19% | 4.38TCr | | +12.41% | 1.99TCr | | +14.56% | 1.72TCr | | -25.77% | 1.5TCr | | -14.93% | 1.44TCr | | -31.27% | 1.18TCr | | -31.93% | 1.16TCr |
Other Specialty Chemicals
|